If you filed a PCT application, the 30/31-month mark is where things get real.
Up to this point, the PCT route has mostly been about keeping your options open. You filed once, bought time, and delayed the expensive country-by-country work. But at 30 or 31 months (depending on the country), you hit the “national phase” deadline. That is the moment you must choose where you want protection and pay to enter those countries.
If you miss it, you usually lose rights in that country.
So this article is here to make that deadline feel simple, not scary. You will learn what actually happens at 30/31 months, what decisions matter, what papers get filed, what costs show up, what delays are possible, and what smart founders do to avoid wasting money while still building a strong moat.
Also, if you want experienced patent support without handing away your company early, Tran.vc can help. We invest up to $50,000 in in-kind patent and IP services for robotics, AI, and deep tech teams. If that sounds useful, you can apply anytime here: https://www.tran.vc/apply-now-form/
PCT National Phase: What Happens at 30/31 Months
Why this moment matters so much
The 30/31-month point is the switch from “global placeholder” to “real country filings.” Until now, your PCT application has helped you hold your place in line across many countries at once. It gave you time to learn, build, and test your market before spending big.
Now, the system asks you to pick actual countries and do the work each one requires. That includes fees, translations, local agents, and forms that must be filed correctly. This is why founders often feel stress here, even if the invention is strong.
If you handle it well, you keep control and protect the best markets. If you handle it poorly, you can burn cash in places that do not matter, or lose rights in the places that do.
What “30 months” versus “31 months” really means
People say “30/31 months” because the deadline is not the same everywhere. Some patent offices set the national phase entry deadline at 30 months from your earliest priority date. Others allow 31 months.
That one-month difference can feel small, but it changes planning. If you assume you have 31 months and one key country is actually 30, you may miss it. Missing it can mean losing the ability to enter that country at all, or needing a costly rescue that may not work.
The simple rule is this: treat 30 months as the safe internal deadline. Build your plan around 30 months, even if some places give you 31.
The priority date is the clock that matters
The month count is based on your earliest priority date, not the PCT filing date. For many startups, that priority date is the date of their first provisional application, or the first non-provisional filing.
This detail matters because founders sometimes look at the wrong date on their calendar. If your first filing was a provisional, the countdown starts there. That means your “30 months” can arrive sooner than you expect if you are only counting from the PCT date.
If your priority chain is messy, or if there were multiple provisionals, you must confirm the earliest one. This is not a place to guess.
What exactly happens when you “enter” national phase
You stop being in a single international track
In the PCT stage, you mostly deal with one filing and one process. After national phase, your single PCT application splits into separate cases in each country you choose.
Each country then becomes its own project, with its own examiner, its own rules, and its own deadlines. That means you now manage a portfolio, not one file.
This is why good planning before entry matters so much. After entry, changes are harder and often more expensive.
You choose where to protect and where to walk away
National phase entry is a business decision disguised as a legal step. The law gives you a deadline, but the real task is deciding where protection is worth it.
If you enter too many countries, you can drain your runway. If you enter too few, you can leave strategic markets open for copying. The right answer depends on where you sell, where others build, and where your future buyers or partners care most.
A strong plan is not “as many countries as possible.” A strong plan is “the few countries that matter most, done well.”
You also choose how to shape the patent claims
National phase is not just about sending forms and paying fees. It is often the best moment to refine your claims based on what you learned during the PCT stage.
By now, you may have an International Search Report and a written opinion. You may also have more product clarity, customer feedback, and a better map of what is truly unique in your system.
A smart team uses that information to strengthen the claim story before each national office starts deeper examination.
The key decisions to make before month 30
Decide your “must-have” countries first
Every founder should start with a small set of must-have places. These are countries where losing rights would hurt your company in a real way.
For many tech startups, must-have places often include the United States and Europe, because they cover large markets and are viewed as high-value by investors. For hardware, robotics, and manufacturing-heavy teams, you may also care about where your product is made.
The right set is not the same for every startup. The point is to pick a core group you will protect no matter what, then decide the rest based on budget and proof.
Decide your “manufacturing risk” countries
If you build physical products, it is not enough to think only about where you sell. You should think about where others could copy and produce.
Manufacturing ecosystems matter. If your product can be copied cheaply in a place where factories are strong and enforcement is difficult, you may want patents there anyway. Not because you plan to sue often, but because the patent can help with customs actions, partnerships, licensing, and negotiation leverage.
This is especially true in robotics, sensors, medical devices, and industrial systems where supply chains shape the competitive field.
Decide your “partner leverage” countries
Sometimes, you file in a country because it helps you close deals. A large buyer may care about protection in their home market. A strategic partner may want to see you have coverage where they operate.
Patents are not only about lawsuits. They are also about trust. They tell others you are serious, and that you built something worth protecting.
If you know you will need a specific channel partner, integrator, or enterprise customer base, consider where they live and what they value.
Decide what you can truly afford for the next two years
National phase is not a one-time cost. Entry is the start of steady spending. You pay at entry, then you pay over time as each office examines your case.
If you enter ten countries now, you are not only paying ten entry fees. You are committing to years of actions, responses, and sometimes translations and renewals. That can surprise teams who thought the big bill was only at month 30.
A practical budget plan looks ahead at least 18 to 24 months after entry. That way you do not abandon cases later due to cash pressure.
The paperwork and steps you will see at entry
The basic filing package is not the same everywhere
Every country wants certain core items at national phase entry. But the exact set differs by office. You should expect forms, fees, and sometimes required documents like copies or statements.
In many places, you will appoint local counsel. That means a local patent attorney or agent who is allowed to file and communicate with the office. Even if you have a main patent team in the US, local rules often require a local representative.
This is why founders often use a coordinating firm to manage the portfolio and keep the process consistent.
Translation is often the biggest surprise
If you enter countries that do not accept English, translation costs can be large. This is not only about translating the claims. In some places, you must translate the full specification, including detailed technical descriptions and drawings text.
Bad translations can hurt you later. A small wording shift can change meaning. In some countries, you may not be allowed to add new content after filing, so you cannot “fix it later” if the translation loses key detail.
If translation is needed, you want a process that includes review by someone who understands the technology. For deep tech, that is not optional.
Fees show up in layers
At entry, you can see several fee types. There are national fees paid to the patent office. There may be additional fees for pages or claims, depending on the office.
Then there are professional fees for local counsel and coordinating counsel. If translation is needed, that is its own line item. When founders see the total, it can feel heavy.
The way to reduce shock is to plan early and pick fewer, better countries rather than many low-value ones.
Timing becomes less flexible after entry
During the PCT stage, you have time buffers and a clear timeline. After entry, each country has its own schedule and response deadlines. Some offices move fast and issue first actions quickly. Others move slowly.
But deadlines are deadlines. If you miss a response window in a country, your application there can die even if other countries are still alive.
This is why simple systems matter. You want clear tracking, clear ownership, and regular reviews so nothing slips.
What founders should do six months before national phase
Treat month 24 as the true start of planning
If you wait until month 29 to plan, you will be rushed. Rushed work leads to bad country choices, sloppy translations, and expensive panic fixes.
A better approach is to start serious planning around month 24. That gives you time to review your search results, refresh your claim strategy, and get real quotes for entry.
It also gives you time to align IP with fundraising. If you plan to raise a seed round near month 30, the IP plan should support that story, not distract from it.
Use your search report to improve your position
The International Search Report and written opinion are valuable because they show what the search examiner found and how they view your claims.
If the report is strong, you can lean into it. If it is weak, you can adjust claims, focus on different inventive angles, and prepare for tougher examination later.
Either way, you do not want to ignore it. Founders who treat the PCT report as “just paperwork” lose a chance to get smarter before spending more.
Align entry countries with real business milestones
A clean approach is to tie each country decision to a real reason. That reason could be revenue targets, known customer locations, regulatory plans, manufacturing, or partnership strategy.
If you cannot explain why you need a country in one clear paragraph, it may not be worth entering now. You can often keep optional countries out of the plan and focus budget on stronger protection in the core markets.
This is how you keep IP spend connected to growth, not separated from it.
Consider Tran.vc support before you spend blindly
This is exactly where many technical founders get stuck. They know IP matters, but they do not want to waste money early or give away control just to pay for patents.
Tran.vc invests up to $50,000 in in-kind patenting and IP services for robotics, AI, and deep tech startups. The goal is to build a real moat early, with real attorneys and clear strategy, so your national phase choices support fundraising and long-term value.
If you want help making these calls with confidence, you can apply anytime here: https://www.tran.vc/apply-now-form/
How to choose the right countries at national phase
Why this choice shapes your company’s future
Country selection is not a legal exercise. It is a business decision that affects your cost, your leverage, and your exit options. Once you enter national phase, you cannot easily undo the choice. If you skip a country, you usually cannot add it later.
This is why experienced founders slow down here. They think about who might buy the company, who might copy the product, and where the real pressure points will be in three to five years.
A good country plan often looks conservative on paper, but powerful in practice.
The United States as the anchor filing
For most AI, software-heavy, and deep tech startups, the United States is the core filing. Investors expect it. Buyers expect it. And enforcement options are stronger than in many regions.
The US system also allows more room to adjust claims during examination. That flexibility can be helpful if your product evolves after filing. But it also means you need a clear story, because examiners will push hard on abstract ideas and obvious combinations.
If the US is your main market or your main fundraising base, this filing is almost always non-negotiable.
Europe and the value of regional coverage
Europe is often treated as one decision, but it is really a bundle of decisions. When you enter the European Patent Office, you are starting a process that can later be validated in individual countries.
This is powerful because one examination can later turn into coverage across many markets. It is also complex, because costs show up later at validation and renewal stages.
Europe matters not only for sales, but also for credibility. Many large companies and strategic partners place high value on European patents, especially in hardware, robotics, medical, and industrial systems.
China and the reality of manufacturing and copying
China is often misunderstood. Some founders think patents there are useless. Others think they are mandatory. The truth sits in the middle.
If your product can be manufactured in China or easily copied by a factory there, a Chinese patent can be a strong defensive tool. It can help with customs actions and can discourage local copying when used correctly.
However, China also requires careful claim drafting and often translation. This is not a filing you do casually. You do it when the business case is clear.
Japan and Korea for advanced tech markets
Japan and Korea matter for certain sectors more than others. If you are in robotics, sensors, automotive systems, advanced materials, or manufacturing tech, these markets can be very important.
Companies in these regions respect patents deeply and often look at them during partnerships or acquisitions. Protection here can increase your leverage in ways that do not show up immediately on a revenue spreadsheet.
If your roadmap includes strategic deals with companies in these regions, national phase entry can be a smart move.
Other regions and the danger of over-filing
It is tempting to add more countries “just in case.” This is where many early-stage teams lose discipline. Each extra country adds cost, management burden, and future obligations.
If a country does not connect to sales, manufacturing, partnerships, or exit value, it is often better to skip it. Patents are not about bragging rights. They are about pressure and protection.
A smaller, well-chosen set of filings is usually stronger than a scattered global footprint.
What happens right after you enter national phase
The waiting period before examination
After national phase entry, nothing dramatic may happen for a while. In some countries, the application sits quietly until the examiner picks it up. In others, you may receive early notices or formalities checks.
This quiet period is not wasted time. It is a chance to prepare. You can review claim strategy, track competitor filings, and align your patent story with your pitch and roadmap.
Founders who forget about patents during this phase often regret it later when an office action arrives suddenly.
First office actions and how to read them
When examination starts, you will receive an office action. This is the examiner’s first real response to your claims. It often includes rejections based on prior art or clarity issues.
This is normal. A first rejection does not mean your invention is weak. It means the process is working. The key is how you respond.
A strong response explains why your invention is different in simple terms and adjusts claims without giving away value. This is where experience matters.
Deadlines and coordination across countries
Each office action comes with a response deadline. These deadlines differ by country and can sometimes be extended, sometimes not.
When you have multiple national cases running at once, coordination becomes important. You may want to keep claim scope aligned across regions, or you may want to adapt it based on local rules.
This is another reason why early planning matters. Once you are in motion, changes are harder to manage.
Common mistakes founders make at 30/31 months
Waiting too long to make decisions
The most common mistake is delay. Founders focus on product, hiring, and fundraising, then realize too late that national phase is around the corner.
This leads to rushed filings, bad translations, and country choices made under stress. The result is often higher cost and weaker protection.
The fix is simple: treat IP as part of company building, not as an afterthought.
Filing everywhere without a strategy
Another mistake is filing in too many countries because it “feels safer.” In reality, this spreads budget thin and weakens your ability to defend or maintain the portfolio.
Patents only help if you can afford to keep them alive and use them when needed. A smaller, focused portfolio is easier to manage and often more respected.
Discipline at this stage pays off later.
Ignoring how investors view your IP
Investors do not count patents the way founders do. They look for alignment between the patents and the business.
If your filings protect the real product, cover key markets, and show thoughtful claim drafting, investors notice. If your portfolio looks random or unfocused, they discount it.
National phase is where that story becomes visible.
How Tran.vc helps founders at national phase
Turning confusion into clear decisions
Tran.vc works with technical founders who know their technology but do not want to become IP experts overnight. At national phase, we help turn a complex legal moment into a clear business plan.
We focus on what matters most, what can wait, and what should be avoided. The goal is not to file more, but to file smarter.
This approach saves money and builds stronger leverage.
Investing in IP instead of taking early equity
Instead of pushing founders to raise too early or give up control, Tran.vc invests up to $50,000 in in-kind patenting and IP services.
That means real strategy, real filings, and real attorney work, without the pressure of chasing a seed round just to pay legal bills.
For deep tech, AI, and robotics teams, this can change the entire early-stage path.
Building patents that support fundraising and exit
We design IP portfolios to support the next step, whether that is seed fundraising, strategic partnerships, or long-term independence.
National phase is not the end of the story. It is the foundation for everything that follows. When done right, it strengthens your position for years.
If you want to approach this milestone with clarity and confidence, you can apply anytime here: https://www.tran.vc/apply-now-form/